Tick-borne encephalitis virus – an emerging pathogen
pdf

Keywords

tick-borne encephalitis virus
TBE
Flavivirus
Ixodese
zoonotic diseas

How to Cite

SOFRONIE, O. and BURLACU, V. (2023) “Tick-borne encephalitis virus – an emerging pathogen”, One Health & Risk Management , p. 44. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/496 (Accessed: 25July2025).

Abstract

Introduction. Tick-borne encephalitis (TBE) is a human viral infectious disease involving the central nervous system, a neglected zoonotic disease caused by tick-borne encephalitis virus (TBEV), belonging to the genus Flavivirus, family Flaviviridae. TBE is mainly transmitted by infected ticks (genus Ixodes) or, in rare cases, by unpasteurized dairy products. TBE is becoming a growing public health challenge in Europe and other parts of the world. The number of human cases of TBE in all endemic regions of Europe has increased considerably in the last decades, risk areas have expanded and new outbreaks have been revealed.

Aim. Analysis and presentation of epidemiological data regarding TBEV presence in Europe and the Republic of Moldova.

Material and methods. Data from the annual reports of the National Agency for Public Health (NAPH), Eurosurveillance outbreak report, and ECDC Annual Epidemiological Report for 2020 were used.

Results. European TBE surveillance data report a stable trend in 2012-2016, though the number of TBE cases reported in Europe, increased during 1990-1994, reflecting the start of surveillance in many countries. Over the next 15 years (1995-2009), the trend was stable, with an annual number of TBE cases fluctuating between 2,000 and 4,000 cases. In 2013, several European countries experienced a peak in TBE cases, resulting in the highest number of TBE cases (>3,000) observed in Europe that year. Since 2017, in European countries has been a gradual increase of reported TBE cases, with a maximum of 3734 confirmed cases in 2020. NAPH data on the TBEV testing of non-human samples from 2017 to 2022 in the Republic of Moldova (central and southern part) reveal the following: in 2017 and 2018, the percentage of positive samples represents 24.8% (12/207). For the last four years (2019-2022), no positive results of the examined tick samples have been reported, the number of ticks tested per year being almost 2 times lower. The test method was mostly the immunoenzymatic assay for the detection of antigen from ticks. During 2017-2022 years, seven human samples (serum) were tested and 2 of them were found positive for IgM and IgG antibodies in patients with a history of tick bite.

Conclusions. TBEV is the most prevalent autochthonous flavivirus in Europe and an important travel-associated virus that causes TBE – a zoonotic disease present in many European countries. TBEV outbreaks are complex and dynamic systems that require specific environmental and climatic characteristics suitable for the life cycle of TBEV vectors and reservoirs, which allow amplification and spread of the virus. If certain environmental factors are altered, stable TBEV outbreaks may disappear, though necessary conditions are met, new TBEV outbreaks may appear. Application and implementation of sensitive and efficient detection techniques will contribute to the improvement of laboratory diagnosis and TBEV national surveillance.

pdf

|Views: 107| |pdf Downloads: 46|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370